Pacira BioSciences, Inc. Insider Trading for May 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. for May 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 77.93 | 64,400 | 5,018,750 | 1,531,307 | 1.6 M to 1.5 M (-4.04 %) |
| May 22 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 77.80 | 3,600 | 280,086 | 1,595,707 | 1.6 M to 1.6 M (-0.23 %) |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 5.49 | 10,000 | 54,900 | 25,532 | |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 5.49 | 6,836 | 37,530 | 35,532 | |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 1.61 | 13,164 | 21,194 | 4,920 | |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 75.00 | 10,000 | 750,000 | 0 | 10 K to 0 (-100.00 %) |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 5.49 | 10,000 | 54,900 | 10,000 | 0 to 10 K |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 74.08 | 20,000 | 1,481,600 | 0 | 20 K to 0 (-100.00 %) |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 5.49 | 6,836 | 37,530 | 20,000 | 13.2 K to 20 K (+51.93 %) |
| May 13 2014 | PCRX | Pacira Pharmaceuti ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 1.61 | 13,164 | 21,194 | 13,164 | 0 to 13.2 K |
| May 12 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 75.76 | 23,220 | 1,759,215 | 1,599,307 | 1.6 M to 1.6 M (-1.43 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Option Exercise | M | 1.61 | 25,000 | 40,250 | 170,695 | |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 74.80 | 300 | 22,440 | 1,208 | 1.5 K to 1.2 K (-19.89 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 74.15 | 17,300 | 1,282,795 | 1,508 | 18.8 K to 1.5 K (-91.98 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Sell | S | 73.40 | 7,400 | 543,160 | 18,808 | 26.2 K to 18.8 K (-28.24 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | President, CEO and ... | Buy | M | 1.61 | 25,000 | 40,250 | 26,208 | 1.2 K to 26.2 K (+2,069.54 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | M | 13.98 | 3,000 | 41,940 | 12,000 | |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | M | 10.81 | 7,000 | 75,670 | 0 | |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Sell | S | 74.67 | 2,500 | 186,675 | 0 | 2.5 K to 0 (-100.00 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Sell | S | 73.57 | 7,500 | 551,775 | 2,500 | 10 K to 2.5 K (-75.00 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Buy | M | 13.98 | 3,000 | 41,940 | 10,000 | 7 K to 10 K (+42.86 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Buy | M | 10.81 | 7,000 | 75,670 | 7,000 | 0 to 7 K |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Option Exercise | M | 1.61 | 15,000 | 24,150 | 17,989 | |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 75.80 | 300 | 22,740 | 5,000 | 5.3 K to 5 K (-5.66 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 75.25 | 11,400 | 857,850 | 5,300 | 16.7 K to 5.3 K (-68.26 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Sell | S | 74.27 | 3,300 | 245,091 | 16,700 | 20 K to 16.7 K (-16.50 %) |
| May 09 2014 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | M | 1.61 | 15,000 | 24,150 | 20,000 | 5 K to 20 K (+300.00 %) |
| May 07 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 75.64 | 600 | 45,386 | 1,622,527 | 1.6 M to 1.6 M (-0.04 %) |
| May 07 2014 | PCRX | Pacira Pharmaceuti ... | Wicki Andreas | Director | Sell | S | 75.78 | 44,180 | 3,348,062 | 1,623,127 | 1.7 M to 1.6 M (-2.65 %) |